[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 72, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 40, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 1144480, "exercisedValue": 0, "unexercisedValue": 760281}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 542544, "exercisedValue": 0, "unexercisedValue": 179487}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 55, "title": "CFO, Principal accounting officer & Principal financial officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 73, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 2, "overallRisk": 8, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 97.21, "open": 99.94, "dayLow": 94.615, "dayHigh": 100.57, "regularMarketPreviousClose": 97.21, "regularMarketOpen": 99.94, "regularMarketDayLow": 94.615, "regularMarketDayHigh": 100.57, "payoutRatio": 0.0, "beta": 1.436, "forwardPE": -42.114407, "volume": 117834, "regularMarketVolume": 117834, "averageVolume": 47540, "averageVolume10days": 82250, "averageDailyVolume10Day": 82250, "bid": 0.0, "ask": 101.0, "bidSize": 0, "askSize": 1, "marketCap": 613232448, "fiftyTwoWeekLow": 4.5, "fiftyTwoWeekHigh": 101.06, "allTimeHigh": 240.0, "allTimeLow": 1.37, "fiftyDayAverage": 48.8477, "twoHundredDayAverage": 39.172825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 560095744, "profitMargins": 0.0, "floatShares": 4083650, "sharesOutstanding": 6169961, "sharesShort": 146898, "sharesShortPriorMonth": 140259, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0238, "heldPercentInsiders": 0.24012, "heldPercentInstitutions": 0.48378, "shortRatio": 3.75, "shortPercentOfFloat": 0.0738, "impliedSharesOutstanding": 6169961, "bookValue": 8.519, "priceToBook": 11.6668625, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -17308382, "trailingEps": -3.84, "forwardEps": -2.36, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 18.56496, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 99.39, "targetHighPrice": 130.0, "targetLowPrice": 80.0, "targetMeanPrice": 102.2, "targetMedianPrice": 104.5, "recommendationMean": 1.36364, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 53250408, "totalCashPerShare": 8.631, "totalDebt": 113740, "quickRatio": 33.626, "currentRatio": 33.94, "debtToEquity": 0.218, "returnOnAssets": -0.39122, "returnOnEquity": -0.59384996, "freeCashflow": -8804239, "operatingCashflow": -9812605, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekChangePercent": 1856.4961, "earningsTimestampStart": 1762864200, "earningsTimestampEnd": 1762864200, "isEarningsDateEstimate": true, "postMarketChangePercent": 1.5494525, "postMarketPrice": 100.93, "postMarketChange": 1.5400009, "regularMarketChange": 2.18, "regularMarketDayRange": "94.615 - 100.57", "fullExchangeName": "NasdaqCM", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1576765800000, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "epsTrailingTwelveMonths": -3.84, "epsForward": -2.36, "epsCurrentYear": -1.67571, "priceEpsCurrentYear": -59.312172, "fiftyDayAverageChange": 50.5423, "fiftyDayAverageChangePercent": 1.0346916, "twoHundredDayAverageChange": 60.217175, "twoHundredDayAverageChangePercent": 1.5372181, "regularMarketChangePercent": 2.24257, "regularMarketPrice": 99.39, "corporateActions": [], "postMarketTime": 1759531719, "regularMarketTime": 1759521601, "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "averageDailyVolume3Month": 47540, "fiftyTwoWeekLowChange": 94.89, "fiftyTwoWeekLowChangePercent": 21.086666, "fiftyTwoWeekRange": "4.5 - 101.06", "fiftyTwoWeekHighChange": -1.6699982, "fiftyTwoWeekHighChangePercent": -0.01652482, "shortName": "Monopar Therapeutics Inc.", "longName": "Monopar Therapeutics Inc.", "cryptoTradeable": false, "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]